| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| SRC |
Malonic acid |
NA |
40000000 |
NA |
NA |
NA |
NA |
PubChem|TTD |
| SRC |
[Hydroxy(6-nitro-1,3-benzodioxol-5-yl)methyl]phosphonic acid |
NA |
300000 |
NA |
NA |
NA |
NA |
BindingDB |
| SRC |
2-[[1-Cyclopentyl-5-[1-(Oxetan-3-Yl)piperidin-4-Yl]pyrazol-3-Yl]amino]pyridine-4-Carbonitrile |
NA |
1010000 |
NA |
NA |
NA |
NA |
TTD |
| SRC |
Tpl2 Kinase Inhibitor |
NA |
400000 |
NA |
NA |
NA |
NA |
TTD |
| SRC |
Oxalic Acid |
NA |
40000000 |
NA |
NA |
NA |
NA |
PubChem|TTD |
| SRC |
Phenethylcarbamoylphosphonic Acid |
NA |
5000000 |
NA |
NA |
NA |
NA |
TTD |
| SRC |
Asp-Arg-Val-Tyr-Val-His-Pro-Phe |
700000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| SRC |
(Benzylamino)carbonylphosphonic acid |
NA |
4400000 |
NA |
NA |
NA |
NA |
TTD |
| SRC |
[4-[(2S)-2-acetamido-3-[[4-(cyclohexylmethyl)-1,3-thiazol-2-yl]methylamino]-3-oxopropyl]phenyl] dihydrogen phosphate |
NA |
483000 |
NA |
NA |
NA |
NA |
TTD |
| SRC |
[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone |
NA |
3210000 |
NA |
NA |
NA |
NA |
TTD |
| SRC |
[4-Amino-2-[[4-[4-(1-methylethyl)-1-piperazinyl]phenyl]amino]-5-thiazolyl](3-methoxyphenyl)methanone |
NA |
3480000 |
NA |
NA |
NA |
NA |
TTD |
| SRC |
3-(4-Phosphonooxy-benzyl)-N-{1-[3-(4-trifluoromethyl-benzyl)-[1,2,4]oxadiazol-5-yl]-ethyl}-succinamic acid |
NA |
102000 |
NA |
NA |
NA |
NA |
TTD |
| SRD5A1 |
4-(1-Cyclohexylmethyl-1H-indol-5-yl)-benzoic acid |
NA |
2100000 |
NA |
NA |
NA |
NA |
TTD |
| SRD5A1 |
4-[1-(1-Propyl-butyl)-1H-indol-5-yl]-benzoic acid |
NA |
3200000 |
NA |
NA |
NA |
NA |
TTD |
| SRD5A1 |
4-(1-Benzhydryl-1H-indol-5-yl)-benzoic acid |
NA |
2780000 |
NA |
NA |
NA |
NA |
TTD |
| SRD5A2 |
4-(1-Benzyl-1H-indol-5-yl)-benzoic acid |
NA |
6200000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| SRD5A2 |
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-[2-(1,2,4-triazol-1-yl)acetyl]-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] cycloheptanecarboxylate |
NA |
98000000 |
NA |
NA |
NA |
NA |
TTD |
| SRD5A2 |
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-[2-(1,2,4-triazol-1-yl)acetyl]-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] cyclopropanecarboxylate |
NA |
118000 |
NA |
NA |
NA |
NA |
TTD |
| SRD5A2 |
1-[(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-imidazol-1-ylethanone |
NA |
118800 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| SRD5A2 |
[(3S,8R,9S,10R,13S,14S)-17-(2-imidazol-1-ylacetyl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate |
NA |
122000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |